Kim Kim SY SY Yin Yin J J Bohlman Bohlman S S Walker Walker P P Dacic Dacic S S Characterization of MET Exon 14 skipping alterations (in NSCLC) and identification of potential therapeutic targets using whole transcriptome sequencing Characterization of MET Exon 14 skipping alterations (in NSCLC) and identification of potential therapeutic targets using whole transcriptome sequencing JTO Clin Res Rep JTO Clin Res Rep 2022 2022 3 3 9 9 100381 100381 supplied-pmid 36082279? Here, MET is linked to non-small cell lung carcinoma.